33 results
8-K
ACGN
Aceragen Inc
4 May 23
Cost Associated with Exit or Disposal Activities
8:52am
of Aceragen, Inc. (the “Company,” “we,” “us,” “our,” and “Aceragen”) approved a reduction in workforce (the “Reduction”) in which approximately 80 … by the Board of certain cost-cutting measures, including the furlough of approximately 46% of the Company’s workforce and the deferral of base salaries
8-K
EX-99.1
ACGN
Aceragen Inc
29 Apr 21
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:15pm
to ILLUMINATE-301’s ORR endpoint, in April 2021 the Company initiated a reduction in force that will impact approximately 50% of our workforce by May … 31, 2021. The decision was made to better align our workforce to our needs in ongoing tilsotolimod and business development activities
8-K
EX-99.1
xmeszf
9 Aug 22
Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
x1dpqg3yp9ne kasvim
9 Aug 21
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
ebypfqojsb114d xjk
8 Nov 21
Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-99.1
jh2h4lwyz
31 Mar 22
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:20pm